Document Type

Article

Publication Date

1-1-2019

Publication Title

Front Pharmacol

Keywords

anticancer; apoptosis induction; cell cycle; cytotoxicity; gene expression; phenol

Abstract

Glioblastoma (GBM) is the most common type of malignant brain tumor in adults. We show here that small molecule 2-[(3,4-dihydroquinolin-1(2H)-yl)(p-tolyl)methyl]phenol (THTMP), a potential anticancer agent, increases the human glioblastoma cell death. Its mechanism of action and the interaction of selective signaling pathways remain elusive. Three structurally related phenolic compounds were tested in multiple glioma cell lines in which the potential activity of the compound, THTMP, was further validated and characterized. Upon prolonged exposer to THTMP, all glioma cell lines undergo p53 and cyclin-dependent kinase mediated cell death with the IC

Clinical Institute

Cancer

Department

Oncology

Department

Institute for Systems Biology

Included in

Oncology Commons

Share

COinS